This study explores the cytotoxic effects of artesunate on retinoblastoma cells, revealing that artesunate selectively induces cell death through interaction with CD71, the transferrin receptor. The findings show that artesunate specifically targets retinoblastoma cells by exploiting the high expression of CD71, offering a novel mechanism for treating this aggressive pediatric